Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 02/14/24
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024PRNewsWire • 02/07/24
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 11/14/23
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023PRNewsWire • 11/06/23
Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in OncologyPRNewsWire • 10/10/23
Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment ConferencePRNewsWire • 08/30/23
Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 08/10/23
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023PRNewsWire • 08/03/23
Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for TransplantPRNewsWire • 07/24/23
Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of DirectorsPRNewsWire • 07/06/23
Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate UpdatePRNewsWire • 06/28/23
Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023PRNewsWire • 06/22/23
Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ TransplantationPRNewsWire • 06/21/23
Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-VestPRNewsWire • 06/14/23
Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in IndiaPRNewsWire • 05/22/23
Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 02/13/23